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 i g  h  l  i  g  h  t  s
Ephrins  are  membrane-bound  ligands  that  control  synaptic  plasticity.
We  described  expression  of  ephrin-B2  in  proprioceptive  DRG  neurons  and  their  afferent  ﬁbers  to the  spinal  cord.
These  data  have  substantial  implications  for  training  of  spinal  locomotor  circuits.
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a  b  s  t  r  a  c  t
Recent  studies  have  shown  that  ephrin-B2  on sensory  afferent  ﬁbers  from  the dorsal  root  ganglia  (DRG)
controls  transmission  of  pain  sensation  to the  spinal  cord.  We  examined  ephrin-B2  expression  in  mouse
DRG  and  spinal  cord  using  an  ephrin-B2/ß-galactosidase  chimeric  allele.  We found  that  ephrin-B2  is
expressed  exclusively  in  proprioceptive  neurons  and  ﬁbers  in neonates,  while  expression  in  lamina  IIIeywords:
phrin
orsal root ganglion
pinal  cord
euron
roprioception
and  IV  of the  adult  spinal  cord  was  observed  in  addition  to that  in  the  deeper  laminae.  We  conﬁrmed  that
ephrin-B2  protein  causes  co-clustering  of  EphB2  and  glutamate  receptors  in  spinal  cord  neurons.  Our
data  are  consistent  with  a role  for ephrin-B2  in  transmission  of  positional  information  to the  CNS,  and
thus  suggest  a  role in  synaptic  plasticity  of  spinal  cord  locomotor  circuits  that  are  known  to be sensitive
to  proprioceptive  sensory  input  after  spinal  cord  injury.
© 2013 The Authors. Published by Elsevier Ireland Ltd.  Open access under CC BY-NC-ND license.. Introduction
Spinal cord injury (SCI) severs the spinal cord locomotor cir-
uitry from its supraspinal input and forms an environment that
s refractory to axonal regrowth [10,31,38]. Much of SCI research
ocuses on ways to promote regeneration of severed axons so as to
estore voluntary control. Recent studies using genetically mod-
ﬁed mouse lines have demonstrated that signiﬁcant long tract
egeneration can be accomplished by targeting speciﬁc genes [28].
owever, accomplishing such regeneration in a therapeutic setting
s difﬁcult [36].
Locomotion in mammals is coordinated by a complex set ofeuronal circuits called the central pattern generator (CPG) that
emain intact below the level of SCI. The CPG can produce step-
ing even when isolated from the brain by SCI. This stepping is
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Open access under CC BYexquisitely sensitive to sensory input from proprioceptive affer-
ents, and plasticity of synapses from these afferents onto the CPG is
associated with training-induced recovery of locomotion after SCI.
Because of this, spinalized cats and rodents and humans with com-
plete injuries can be trained to perform complicated weight bearing
and stepping tasks independent of voluntary control [5,14,29,33].
Understanding the connectivity of the sensory system to the spinal
cord is therefore necessary to exploit any voluntary control that
remains after incomplete SCI or that may  be regained through
regenerative therapies.
Synapses  in the CNS form from highly mobile ﬁlopodia that
extend from growing dendrites. Once they make connections
with their target axons, they grow mature spines, from which
boutons form with post-synaptic densities (PSD) to match the pre-
synaptic ones across the synaptic cleft. The neurotransmitter of
choice in the CNS is glutamate, and is detected in the PSD by
N-methyl-d-aspartate receptors (NMDAR) or -amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid receptors (AMPAR) [24]. Part
of the stabilization process of the synapse is the clustering of these
receptors, and Eph/ephrin signaling is an integral part of this pro-
cess [7,23].
Eph  receptor tyrosine kinases are classiﬁed as A or B
based on phylogenetic similarity and their afﬁnities for the
-NC-ND license.
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lycosylphosphatidyl inositol-linked ephrin-As or the transmem-
rane ephrin-Bs, although some members bind promiscuously
cross classes. Binding to Ephs can also initiate “reverse signaling”
nto ephrin-bearing cells. Both forward and reverse signaling are
ntimately involved with axon guidance and synaptic plasticity in
he brain [24,27].
There  is mounting evidence that forward signaling also plays
 critical role in synaptic plasticity between the sensory system
nd its spinal cord targets. Battaglia et al. reported that treat-
ent of rat spinal cords with ephrin/Fc soluble protein induced
hermal hyperalgesia and mechanical allodynia in rats and that
dministration of an EphB1/Fc protein to block ephrin signaling
n the spinal cord alleviated this hyper-sensitivity [1]. These and
ther authors’ data indicate that ephrin-Bs on presynaptic sen-
ory afferents, especially ephrin-B2 (EB2), interact with EphBs
n spinal cord neurons in the dorsal horns to cause clustering
nd activation of NMDARs and thus hypersensitivity to painful
timuli. A recent study by Han et al. indicates that EphB1 may
e the post-synaptic mediator of this effect, as EphB1 knock-
ut mice in their hands demonstrated a reduced response to
europathic pain compared to wild type [18]. And Zhao et al. doc-
mented deﬁcits in inﬂammatory and neuropathic (but not acute)
ain responses in a nociceptor-speciﬁc EB2 conditional knockout
40].
We examined EB2 expression in the spinal cord using a
-galactosidase (ß-gal) indicator mouse line, and found expres-
ion in ﬁbers that innervated deeper laminae corresponding to
echanoreceptive and proprioceptive input. Our ﬁndings suggest
hat ephrin-B2 may  play a role in sensory input to the CPG, and
hus may  modulate locomotion in a previously undescribed man-
er.
. Materials and methods
.1.  Mouse strains
Ephrin-B2/LacZ (EB2LZ) mice encoding a chimeric protein with
 ß-gal moiety replacing the intracellular segment of ephrin-B2
EB2), are described in [13]. EphB2/LacZ mice, carrying a LacZ cDNA
n place of the intracellular domain of EphB2 are described in [22].
.2. Mouse surgeries
Adult  EB2LZ mice were anesthetized and their left dorsal roots
t lumbar levels four and ﬁve were cut and ligated as described in
32]. The mice were sacriﬁced 15 days later, and perfused with 4%
ormaldehyde.
.3. DiI tracing
Lumbar DRGs still attached to the spinal cords of newborn
B2LZ homozygotes were ﬁxed and injected with 1,1′-dioctadecyl-
,3,3′3′-tetramethylindocarbocyanine perchlorate (DiI). After one
eek in 4C, the tissues were embedded in agarose and sectioned
erially at 50 m on a vibratome. Sections were examined immedi-
tely under ﬂuorescence microscopy with a Texas Red ﬁlter. Digital
mages were recorded with a Cool Pix digital camera. Wild type lit-
ermate controls were processed alongside homozygotes and their
fferent patterns compared.
.4.  Immunoﬂuorescence and ß-galactosidase stainsTissues perfused with 4% formaldehyde were equilibrated in
0% sucrose and cryosectioned at 12 mm.  Sections were stained
ith X-gal to detect ß-gal activity [2] or immunolabeled withLetters 545 (2013) 69– 74
antibodies  against ß-gal (Millipore AB986) and parvalbumin (Mil-
lipore MAB1572). Myelinated and unmyelinated afferent ﬁbers to
the spinal cord dorsal horn were detected with antibodies against
NF200 (Sigma N5389) and CGRP (Sigma C7113), respectively. Pri-
mary spinal cord neurons were incubated with anti-EphB2 (R&D
Systems) and anti-NR1 (Cell Signaling). Primary antibodies were
detected with donkey anti-goat, goat anti-mouse, or goat anti-
rabbit Cy2 or Cy3 conjugated secondary antibodies from Jackson
ImmunoResearch.
2.5. In situ hybridization
EB2  cDNA from RT-PCR of mouse brain RNA was subcloned into
pBluescriptSK(-) (Stratagene) and used to create DIG-labeled cRNA
probes by in vitro transcription [2].
2.6. Primary neuron cell cultures
DRGs from e13.5 EB2LZ± mouse embryos were isolated as pre-
viously described [25] and grown in Neurobasal medium supple-
mented with B27 and Nerve Growth Factor (NGF, 10 ng/ml), Brain-
Derived Neurotrophic Factor (BDNF, 2 ng/ml), or Neurotrophin-3
(NT-3, 2 ng/ml). After 48 h in culture, cells were ﬁxed and stained
with X-gal. Adult spinal cord neurons were isolated as previously
described [2] and grown for 48 h in the presence of 4 g/ml EB2/Fc
protein preclustered with anti-Fc antibody. Area and number anal-
yses were done with ImageJ software.
3. Results
3.1. Expression of EB2 in proprioceptive afferents
We examined EB2LZ mice in which a ß-gal moiety replaces
the intracellular domain of the ephrin. ß-Gal expression in this
mouse gives a faithful representation of the EB2 expression pattern
[6,11,12,34]. We  used this mouse rather than anti-EB2 immuno-
cytochemistry because the available EB2 antibodies are known
to be non-speciﬁc in that they cross-react heavily with EB1 and
may also cross-react with other ephrins depending on experi-
mental conditions (manufacturer’s literature and author’s personal
observations). X-gal staining of adult EB2LZ spinal cord revealed a
sweeping pattern from the dorsal horns down to the inner lami-
nae on each side of the central canal, and to a lesser extent into
the ventral horns (Fig. 1). The same pattern was observed at cervi-
cal, thoracic, and lumbar levels. Although cell bodies in the deeper
laminae stained positive, three pieces of evidence indicated that
this staining was  primarily in the afferent ﬁbers emanating from
the DRG rather than from cells of the spinal cord. First, EB2LZ
staining was  evident in neurons and axons in the DRG (Fig. 1D).
Second, in situ hybridization of spinal cord sections showed lit-
tle EB2 mRNA signal except in a few cells around the central
canal, consistent with the large blue cells seen in the same area
in X-gal stains (Fig. 1A, C and F). Third, we  performed unilateral
dorsal rhizotomies on EB2LZ mice, and examined X-gal stain-
ing in the spinal cords seven days later. Staining was  evident on
the uncut side, but much reduced on the cut side (Fig. 2). These
data are in agreement with published ﬁndings of EB2 on sen-
sory afferents, but identify different targets within the spinal cord
[1,26,37,40].
Four pieces of evidence in our hands strongly suggest that EB2 is
on those ﬁbers that carry proprioceptive input. First, the innerva-
tion pattern in adult X-gal stained EB2LZ spinal cords penetrates
past the superﬁcial laminae that receive nociceptive input and
deep into the ventral horns, where the motor neurons that con-
trol locomotion are found. Many of the stained ﬁbers appear to
terminate at the base of the dorsal horn in the area of Clark’s
S.M. Logan et al. / Neuroscience Letters 545 (2013) 69– 74 71
Fig. 1. EB2LZ is expressed in spinal cord and afferent ﬁbers from the DRG. (A–C) transverse sections of EB2LZ/+ spinal cords stained with X-gal (A) is 40× (B and C) are
200× magniﬁcation of the boxes in A. (D) DRG at 100×. (E) Histogram of the sizes of 206 DRG neurons from three EB2LZ/+ mice. X-gal-positive (blue) cells are closed bars;
X-gal-negative cells are open bars. Eighteen percent of cells were blue. Avg. size = 1056 ± 77 m2 for blue vs. 433 ± 20 m2 for red; p < 0.0001 by Student’s t-test). (F) EB2 in
situ  hybridization of spinal cord at 40×. (For interpretation of the references to color in this text, the reader is referred to the web version of the article.)
Fig. 2. Loss of EB2LZ ﬁbers after dorsal rhizotomy. X-gal stain of EB2LZ spinal cord with L4 dorsal root transection (right side) 7 days before sacriﬁce.
72 S.M. Logan et al. / Neuroscience Letters 545 (2013) 69– 74
Fig. 3. EB2 expression in proprioceptive sensory neurons and afferents at birth and in adult dorsal horn. (A) Neonatal EB2LZ spinal cords and DRGs immunolabeled with
anti-ßgal (red) and anti-parvalbumin (green) antibodies. (B) EB2LZ/+ spinal cord stained with X-gal (panel i) and processed for immunoﬂuorescence to detect NF200 (panel
ii,  red) and CGRP (panel iii, green). Panels i–iii are merged in iv. Rexed’s laminae are indicated by dotted lines. Arrowheads show boundaries of CGRP expression. Arrows
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olumn, a spinal cord nucleus that runs from cervical to lumbar
evels and carries proprioceptive information to the cerebellum
Fig. 1A and C) [19]. Second, a small subset (18%) of the largest
eurons in the DRG of adult EB2LZ mice are ß-gal positive, con-
istent with expression in the medium-sized mechanoreceptive
nd large proprioceptive neurons, rather than the more numerous
nd smaller nociceptors [32] (Fig. 1D and E). Third, we  cultured
mbryonic day 13.5 mouse DRG neurons from EB2LZ mice and
rew them in the presence of NGF, BDNF, or NT-3. At this stage in
evelopment, DRG neurons that send out nociceptive, mechanore-
eptive, or proprioceptive afferents are dependent for survival
n these neurotrophins, respectively [25]. We  found ß-gal pos-
tive neurons only in the NT-3-dependent population that gives
ise to proprioceptive neurons (data not shown). Fourth, the pat-
ern of ß-gal in EB2LZ neonatal spinal cord and DRG overlaps
hat of parvalbumin, a marker for proprioceptive neurons [4]
Fig. 3A).
Strong X-gal stain was seen in the adult dorsal horn, indicating
 broader pattern of expression than in the neonate. Nevertheless,
he EB2/ß-gal signal was still restricted to myelinated ﬁbers (identi-
ed by NF200 immunoreactivity) that innervate laminae III and IV.
hese are primarily from Aß mechanoreceptors and A∂ nociceptors.rpretation of the references to color in this text, the reader is referred to the web
EB2  was  speciﬁcally excluded from the CGRP-positive, unmyeli-
nated C ﬁbers that innervate lamina II (Fig. 3B).
3.2. EB2 does not mediate axon guidance from sensory neurons
We  examined the anatomy of EB2LZ homozygous neonates, in
which reverse signaling is absent due to the lack of an EB2 intra-
cellular domain, using both anti-parvalbumin immunoﬂuorescence
(Fig. 3) and DiI ﬁlling of L4 DRG to label sensory afferents in the cord
(Suppl. Fig. 1). These mice showed no gross axon guidance defects.
Thus, we conclude that EB2 is not likely to control developmental
guidance of sensory axons.
3.3.  Eph expression in the spinal cord
Our examination of the EphB2-LacZ knock-in mouse [22]
revealed EphB2/ß-gal expression primarily in the dorsal horns of
the spinal cord in a pattern that mirrors the path of incoming sen-
sory ﬁbers, and also in some cells of the ventral horn. We  did not
observe ß-gal in the DRG or in the dorsal root (Suppl. Fig. 2). EphA4
is also expressed in spinal cord motor neurons [21]. These expres-
sion patterns agree with the in situ hybridization patterns for these
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wo Ephs documented in the Allen Brain Atlas. Both Ephs are phys-
ological binding partners for EB2 in other situations, and have
een described in synapse formation elsewhere in the CNS [16,39].
hus, both are candidate receptors for the EB2 on sensory affer-
nts. We  isolated spinal cord neurons and treated them in culture
ith clustered recombinant EB2/Fc protein and observed EphB2 in
hese neurons co-clustering with NMDA receptors. EB2 treatment
ncreased the size of these clusters, consistent with a role in synapse
trengthening (Suppl. Fig. 3). This data agrees with previous reports
nd underscores the likelihood that EB2 controls sensory plasticity
n the spinal cord [1,3].
.  Discussion
Whereas previous studies described immunodetection of EB2
n the dorsal horns, we discovered EB2/ß-gal in ﬁbers innervat-
ng the deeper laminae assigned to proprioceptive afferents. Of
articular note was the concentration of ß-gal positive ﬁbers and
ells in the region corresponding to Clarke’s Column. This nucleus
tretches from cervical to lumbar levels in the cord and relays pro-
rioceptive input to the brain. Given recent work that described
 role for EB2 in chronic pain [1,9,26,37,40], we  were surprised
o ﬁnd EB2LZ in the developing sensory system conﬁned to pro-
rioceptive DRG neurons and their ﬁbers, with no expression in
ociceptors. In adult spinal cords, we observed EB2LZ ﬁbers in
aminae III and IV in the dorsal horn, but not in lamina II. Our
ata contradict the ﬁndings of Battaglia et al. which described EB2
mmunoreactivity in this superﬁcial lamina and in small diam-
ter DRG neurons [1]. This disagreement may  be explained by
ross-reactivity of the antibodies used by these investigators for
 ephrins. Nevertheless, the literature ﬁrmly implicates EB2 sig-
aling in pain sensation. Zhao and colleagues generated an EB2
onditional knockout mouse using a nociceptor-selective Nav1.8
re and reported that the mutants exhibited deﬁcits in chronic
ain perception [40]. Nav1.8 is expressed in A∂ and Aß as well
s C ﬁbers [8], and our data suggest that knockout of EB2 in A∂
ociceptors may  explain the observed phenotype, as well as in
ow-threshold Aß mechanoreceptors that are sensitized by chronic
nﬂammation [15]. Our observation that EB2 is not expressed in
ociceptors at birth might explain why Zhao’s mutant showed no
cute pain phenotype resulting from developmental defects, but
ather a chronic pain phenotype that involves post-developmental
lasticity.
Our ﬁndings have practical implications for translational manip-
lation of sensory circuits in the spinal cord. First, as noted above,
PG locomotor circuits are highly plastic and susceptible to posi-
ional input once separated from the brain. This principle is being
sed to increase weight-bearing and stepping in quadriplegics
hrough Lokomat therapy [20,35]. If ephrin-induced plasticity can
e activated, perhaps by injection of ephrin/Fc proteins, it might
reatly increase the gains earned with training. At the same
ime, others have reported that injecting the rodent spinal cord
ith unclustered ephrin blocking proteins suppresses chronic pain
9,37], thus potentially causing a therapeutic “conﬂict of interest”.
ctivating Eph signaling in the spinal cord to improve locomotion
ight increase pain in the patient, while blocking pain by block-
ng Eph activation might inhibit the plasticity necessary for motor
ains. Additionally, blocking of Eph signaling post-SCI has been
eported to reduce the glial scar around the injury and increase
egeneration and recovery [17,30]. However, the same blocking
trategy may  impair the plasticity necessary for the spinal circuits
hat would supposedly be targeted by regenerating supraspinal
xons. Thus, our work highlights the necessity of learning the exact
ole of each ephrin and Eph in the spinal cord and ﬁnding a balance
etween each of these systems.
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Appendix A. Supplementary data
Supplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/
j.neulet.2013.04.025.
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